Literature DB >> 34953915

MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages.

Hiroyuki Kato1, Keisuke Tateishi2, Hiroaki Fujiwara3, Takuma Nakatsuka1, Keisuke Yamamoto1, Yotaro Kudo1, Yoku Hayakawa1, Hayato Nakagawa1, Yasuo Tanaka1, Hideaki Ijichi1, Motoyuki Otsuka1, Dosuke Iwadate1, Hiroki Oyama1, Sachiko Kanai1, Kensaku Noguchi1, Tatsunori Suzuki1, Tatsuya Sato1, Ryunosuke Hakuta1, Kazunaga Ishigaki1, Kei Saito1, Tomotaka Saito1, Naminatsu Takahara1, Takahiro Kishikawa1, Tsuyoshi Hamada1, Ryota Takahashi1, Koji Miyabayashi1, Suguru Mizuno1, Hirofumi Kogure1, Yousuke Nakai4, Yoshihiro Hirata5, Atsushi Toyoda6, Kazuki Ichikawa7, Wei Qu7, Shinichi Morishita7, Junichi Arita8, Mariko Tanaka9, Tetsuo Ushiku9, Kiyoshi Hasegawa8, Mitsuhiro Fujishiro1, Kazuhiko Koike1.   

Abstract

BACKGROUND & AIMS: Chromatin architecture governs cell lineages by regulating the specific gene expression; however, its role in the diversity of cancer development remains unknown. Among pancreatic cancers, pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasms (IPMN) with an associated invasive carcinoma (IPMNinv) arise from 2 distinct precursors, and their fundamental differences remain obscure. Here, we aimed to assess the difference of chromatin architecture regulating the transcriptional signatures or biological features in pancreatic cancers.
METHODS: We established 28 human organoids from distinct subtypes of pancreatic tumors, including IPMN, IPMNinv, and PDAC. We performed exome sequencing (seq), RNA-seq, assay for transposase-accessible chromatin-seq, chromatin immunoprecipitation-seq, high-throughput chromosome conformation capture, and phenotypic analyses with short hairpin RNA or clustered regularly interspaced short palindromic repeats interference.
RESULTS: Established organoids successfully reproduced the histology of primary tumors. IPMN and IPMNinv organoids harbored GNAS, RNF43, or KLF4 mutations and showed the distinct expression profiles compared with PDAC. Chromatin accessibility profiles revealed the gain of stomach-specific open regions in IPMN and the pattern of diverse gastrointestinal tissues in IPMNinv. In contrast, PDAC presented an impressive loss of accessible regions compared with normal pancreatic ducts. Transcription factor footprint analysis and functional assays identified that MNX1 and HNF1B were biologically indispensable for IPMN lineages. The upregulation of MNX1 was specifically marked in the human IPMN lineage tissues. The MNX1-HNF1B axis governed a set of genes, including MYC, SOX9, and OLFM4, which are known to be essential for gastrointestinal stem cells. High-throughput chromosome conformation capture analysis suggested the HNF1B target genes to be 3-dimensionally connected in the genome of IPMNinv.
CONCLUSIONS: Our organoid analyses identified the MNX1-HNF1B axis to be biologically significant in IPMN lineages.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromatin Structure; Epigenetics; HNF1B; Intraductal Papillary Mucinous Neoplasm; MNX1

Mesh:

Substances:

Year:  2021        PMID: 34953915     DOI: 10.1053/j.gastro.2021.12.254

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Peak density of immature nerve cells occurs with high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Vincent Quoc-Huy Trinh; Joseph Thomas Roland; Jahg Wong; Frank Revetta; Krutika Patel; Chanjuan Shi; Kathleen E DelGiorno; Bruce D Carter; Marcus Chuan Beng Tan
Journal:  J Pathol       Date:  2022-07-18       Impact factor: 9.883

Review 2.  Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma.

Authors:  Marcus T T Roalsø; Øyvind H Hald; Marina Alexeeva; Kjetil Søreide
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 3.  Organoids in gastrointestinal diseases: from experimental models to clinical translation.

Authors:  Claudia Günther; Beate Winner; Markus F Neurath; Thaddeus S Stappenbeck
Journal:  Gut       Date:  2022-05-30       Impact factor: 31.793

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.